INVA Competitors & Alternatives
Compare Innoviva Inc with similar stocks in the same industry
Biotechnology
INVA
Main Stock$21.70
Tradestie Score
61
Market Cap
$1.15B
P/E Ratio
3.4
Revenue Growth
0.1%
Analyst Upside
+63.6%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MNKD
Mannkind Corporation
|
$3.36
|
$1.65B | - | 58 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$36.21
|
$1.63B | - | 61 | Compare |
|
BHVN
Biohaven Ltd.
|
$10.81
|
$1.57B | - | 55 | Compare |
|
VCEL
Vericel Corporation
|
$34.74
|
$1.56B | 80.1 | 60 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$84.97
|
$1.55B | - | 56 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$32.10
|
$1.55B | 12.5 | 69 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$30.14
|
$1.55B | - | 55 | Compare |
|
NVAX
Novavax Inc
|
$10.20
|
$1.54B | - | 59 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$15.67
|
$1.50B | 7.1 | 60 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$37.50
|
$1.50B | - | 57 | Compare |
More INVA Analysis
Data updated: Jun 03, 2026 | Industry: Biotechnology (SIC 2834)
225 stocks in this industry